Christchurch researchers get HRC funding
Embargoed until Wednesday July 20,
2011
Christchurch researchers get HRC funding
Professor David Fergusson of the University of Otago, Christchurch, and his team have been granted almost $4 million by the Health Research Council (HRC) to continue work on their world-renowned longitudinal study, including measuring the psychological toll of the Canterbury earthquakes.
Professor Fergusson’s Health and Development Study has been running for more than 30 years. Its findings have shaped Government policy and enlightened New Zealanders about the exact impact of childhood disadvantages on later life outcomes.
The HRC funding
will allow Professor Fergusson and his team to study
participants to age 35, across a range of measures.
Information was first collected about participants, and
their families, when they were infants.
Professor
Fergusson says he will look at the consequences of the 2010
Canterbury earthquake for those study participants who
experienced it. He will be able to compare outcomes for them
with participants who were not in Canterbury at that
time.
Other Christchurch research teams funded by the
HRC include:
• Head of the University of Otago,
Christchurch’s, Psychological Medicine department,
Professor Roger Mulder was granted $726,684 for a study
using modified cognitive behavioural treatment for
non-cardiac chest pain. Chest pain is one of the most
common reasons for presenting to emergency departments. But
the majority of chest pain is not cardiac in origin. Current
ways of dealing with this, such as reassurance, are not very
effective. Professor Mulder will evaluate a brief
psychosocial intervention to reduce distress, and teach
coping skills, stress management and cardiac risk factor
reduction to see if the intervention results in less use of
health resources and better quality of life for
patients.
•
•
• Associate Professor Marie
Crowe from the Psychological Medicine department has been
granted $1,189,961 to research the effectiveness of a
Biopolar Disorder Clinic. The trial addresses a gap in
mental health care for this group after they are released
from specialist mental health services. The Biopolar
Disorder Clinic focuses on a combination of psychotherapy
and medication management. At the moment people with bipolar
disorder normally have follow-up appointments with a GP
except for acute instances.
•
•
• Associate
Professor Lisa Stamp was granted $1,199,225 to study the
safety and efficacy of increasing the recommended dose of
the most commonly prescribed gout medication. There is
evidence many patients fail to achieve adequate reduction in
required blood urate levels, at recommended doses.
Preliminary evidence shows increasing dose is safe and
effective.
•
•
• Professor Mark Richards,
head of the Christchurch Cardioendocrine Research Group, had
his research funding extended ($3,430,492) so his team can
continue work on the Hauora Manawa/Community Heart Study, a
study into the prediction of onset and outcomes in coronary
heart disease and research to develop a range of specific
tests for acute cardiac
injury.
•
•
• Associate Professor Margreet
Vissers will receive $812,985 to study the impact of
vitamin-C on cancerous tumour growth in an animal
model.
•
•
ends